Colleen Kusy's Stock Ratings

Baird Analyst

Colleen Kusy is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-14.8%

Smart Score

35.4%

Overall Average Return Percentile

16th

Number of Ratings

53
Buy NowGet Alert
03/13/2025OCSBuy Now
Oculis Holding
$18.41122.71%
Colleen Kusy35%
$37 → $41MaintainsOutperformGet Alert
03/12/2025AGENBuy Now
Agenus
$1.7373.41%
Colleen Kusy35%
$6 → $3MaintainsNeutralGet Alert
12/05/2024CHRSBuy Now
Coherus BioSciences
$0.88581.82%
Colleen Kusy35%
$4 → $6MaintainsOutperformGet Alert
11/15/2024ELVNBuy Now
Enliven Therapeutics
$20.2897.24%
Colleen Kusy35%
$32 → $40MaintainsOutperformGet Alert
11/13/2024SYREBuy Now
Spyre Therapeutics
$17.91262.93%
Colleen Kusy35%
$50 → $65MaintainsOutperformGet Alert
11/08/2024CHRSBuy Now
Coherus BioSciences
$0.88354.55%
Colleen Kusy35%
$8 → $4MaintainsOutperformGet Alert
11/07/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41125.32%
Colleen Kusy35%
$92 → $55MaintainsOutperformGet Alert
09/23/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41276.89%
Colleen Kusy35%
$96 → $92MaintainsOutperformGet Alert
08/14/2024MRSNBuy Now
Mersana Therapeutics
$0.47539.66%
Colleen Kusy35%
$4 → $3MaintainsNeutralGet Alert
08/09/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41293.28%
Colleen Kusy35%
$86 → $96MaintainsOutperformGet Alert
08/08/2024OCULBuy Now
Ocular Therapeutix
$7.45128.19%
Colleen Kusy35%
$18 → $17MaintainsOutperformGet Alert
07/26/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41252.31%
Colleen Kusy35%
$100 → $86MaintainsOutperformGet Alert
07/23/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41309.67%
Colleen Kusy35%
$100 → $100MaintainsOutperformGet Alert
07/01/2024CHRSBuy Now
Coherus BioSciences
$0.88809.09%
Colleen Kusy35%
$9 → $8MaintainsOutperformGet Alert
06/28/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41309.67%
Colleen Kusy35%
$100 → $100MaintainsOutperformGet Alert
06/11/2024OCSBuy Now
Oculis Holding
$18.41100.98%
Colleen Kusy35%
$35 → $37MaintainsOutperformGet Alert
06/11/2024ELVNBuy Now
Enliven Therapeutics
$20.2857.79%
Colleen Kusy35%
→ $32Initiates → OutperformGet Alert
05/02/2024SYREBuy Now
Spyre Therapeutics
$17.91179.17%
Colleen Kusy35%
→ $50Initiates → OutperformGet Alert
03/19/2024OCSBuy Now
Oculis Holding
$18.4190.11%
Colleen Kusy35%
$64 → $35MaintainsOutperformGet Alert
03/12/2024ORICBuy Now
ORIC Pharmaceuticals
$7.63227.65%
Colleen Kusy35%
$27 → $25ReiteratesOutperform → OutperformGet Alert
02/29/2024MRSNBuy Now
Mersana Therapeutics
$0.47966.1%
Colleen Kusy35%
$1 → $5MaintainsNeutralGet Alert
02/23/2024NUVLBuy Now
Nuvalent
$76.6636.97%
Colleen Kusy35%
→ $105Initiates → OutperformGet Alert
02/06/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41231.83%
Colleen Kusy35%
→ $81ReiteratesOutperform → OutperformGet Alert
01/23/2024CHRSBuy Now
Coherus BioSciences
$0.88922.73%
Colleen Kusy35%
$11 → $9MaintainsOutperformGet Alert
01/17/2024APLSBuy Now
Apellis Pharmaceuticals
$24.41231.83%
Colleen Kusy35%
$71 → $81MaintainsOutperformGet Alert
11/17/2023CHRSBuy Now
Coherus BioSciences
$0.881150%
Colleen Kusy35%
→ $11Initiates → OutperformGet Alert
09/14/2023OCULBuy Now
Ocular Therapeutix
$7.45141.61%
Colleen Kusy35%
→ $18ReiteratesOutperform → OutperformGet Alert
08/01/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41186.77%
Colleen Kusy35%
$115 → $70MaintainsOutperformGet Alert
07/28/2023MRSNBuy Now
Mersana Therapeutics
$0.47113.22%
Colleen Kusy35%
$7 → $1DowngradeOutperform → NeutralGet Alert
06/20/2023SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
—DowngradeOutperform → NeutralGet Alert
06/13/2023OCULBuy Now
Ocular Therapeutix
$7.4561.07%
Colleen Kusy35%
$10 → $12MaintainsOutperformGet Alert
06/08/2023OCSBuy Now
Oculis Holding
$18.41215.05%
Colleen Kusy35%
→ $58Initiates → OutperformGet Alert
06/06/2023AGENBuy Now
Agenus
$1.73362.43%
Colleen Kusy35%
→ $160Initiates → OutperformGet Alert
05/04/2023SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
→ $6MaintainsOutperformGet Alert
05/04/2023ISEEBuy Now
IVERIC bio
——
Colleen Kusy35%
→ $40DowngradeOutperform → NeutralGet Alert
04/21/2023OCULBuy Now
Ocular Therapeutix
$7.45141.61%
Colleen Kusy35%
→ $18Initiates → OutperformGet Alert
02/21/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41330.15%
Colleen Kusy35%
$90 → $105MaintainsOutperformGet Alert
11/15/2022HARPBuy Now
Harpoon Therapeutics
——
Colleen Kusy35%
—DowngradeOutperform → NeutralGet Alert
11/03/2022SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
$11 → $6MaintainsOutperformGet Alert
10/19/2022AVEOBuy Now
AVEO Pharmaceuticals
——
Colleen Kusy35%
$17 → $15DowngradeOutperform → NeutralGet Alert
09/07/2022ISEEBuy Now
IVERIC bio
——
Colleen Kusy35%
$27 → $34MaintainsOutperformGet Alert
08/09/2022MRSNBuy Now
Mersana Therapeutics
$0.474164.39%
Colleen Kusy35%
$18 → $20MaintainsOutperformGet Alert
08/05/2022KPTIBuy Now
Karyopharm Therapeutics
$5.83140.14%
Colleen Kusy35%
$255 → $210MaintainsOutperformGet Alert
08/03/2022SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
$11 → $11MaintainsOutperformGet Alert
05/09/2022SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
$11 → $11MaintainsOutperformGet Alert
04/13/2022SURFBuy Now
Surface Oncology
——
Colleen Kusy35%
→ $11MaintainsOutperformGet Alert
04/07/2022IOVABuy Now
Iovance Biotherapeutics
$3.62839.49%
Colleen Kusy35%
$30 → $34MaintainsOutperformGet Alert
03/03/2022ISEEBuy Now
IVERIC bio
——
Colleen Kusy35%
→ $27Initiates → OutperformGet Alert
02/25/2022IOVABuy Now
Iovance Biotherapeutics
$3.62728.96%
Colleen Kusy35%
$35 → $30MaintainsOutperformGet Alert
11/02/2021SABSBuy Now
SAB Biotherapeutics
$1.701252.94%
Colleen Kusy35%
→ $230Initiates → OutperformGet Alert
05/06/2020IOVABuy Now
Iovance Biotherapeutics
$3.621696.08%
Colleen Kusy35%
$60 → $65MaintainsOutperformGet Alert
11/05/2019IOVABuy Now
Iovance Biotherapeutics
$3.621557.92%
Colleen Kusy35%
$56 → $60MaintainsOutperformGet Alert
02/07/2019IOVABuy Now
Iovance Biotherapeutics
$3.62701.33%
Colleen Kusy35%
→ $29Initiates → OutperformGet Alert